22nd Century Group Inc (XXII): Oh Goody. A New York Times hit piece on...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

22nd Century Group Inc (XXII)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	70
Boards Moderated	0
Alias Born	01/27/2018

Re: brooklyn13 post# 49637

Sunday, 10/13/2019 7:06:32 PM

Sunday, October 13, 2019 7:06:32 PM

Oh Goody. A New York Times hit piece on Trump.

You seem to take pride in posting an article about the Trump Administration from Fake News New York Times. Trump exposed them for what they are back in 2016. The Main Stream Media will NEVER say something positive about Trump.

Now don't get me wrong, the FDA should have already given 22nd Century the green light on their VLN solution to nicotine addiction. Keep in mind First Lady Melania Trump has already tweeted on the vaping epidemic and President Trump added his comment within a few hours.

Like him or not, Trump has shown that he cannot be bought and is willing to fight for what's good for ALL citizens of the USA.

Business in the USA has become too political. Professional politicians only respond to the Power Brokers who fund their elections. I own XXII because Trump IS in office.

By the way, remember on Nov 8, 2016 the New York Times ran a story giving Crooked Hillary at 85% chance of winning.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent XXII News

Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:10:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 01:30:13 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/24/2024 09:31:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:30:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:04:11 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:02:41 PM
22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction • GlobeNewswire Inc. • 12/04/2023 12:07:00 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 10:18:00 PM
Pharma Stock Up Big After Second Major Announcement This Week • AllPennyStocks.com • 11/29/2023 03:55:00 PM
Pharma Stock Up Big After Second Major Announcement This Week • AllPennyStocks.com • 11/29/2023 03:55:00 PM
22nd Century Appoints Larry Firestone as Chairman and CEO • GlobeNewswire Inc. • 11/29/2023 12:07:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:56:49 PM
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise • GlobeNewswire Inc. • 11/27/2023 09:44:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 11:01:36 AM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:19:32 PM
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores • GlobeNewswire Inc. • 11/08/2023 06:15:00 PM
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License • GlobeNewswire Inc. • 11/07/2023 01:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 12:30:19 PM
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/06/2023 12:30:00 PM
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
22nd Century Group (XXII) Reduces Debt by $8.1 Million • GlobeNewswire Inc. • 10/25/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:34:05 PM

More XXII News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow